BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3190058)

  • 1. Zidovudine for the treatment of thrombocytopenia associated with human immunodeficiency virus (HIV). A prospective study. The Swiss Group for Clinical Studies on the Acquired Immunodeficiency Syndrome (AIDS).
    Ann Intern Med; 1988 Nov; 109(9):718-21. PubMed ID: 3190058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial.
    Marroni M; Gresele P; Landonio G; Lazzarin A; Coen M; Vezza R; Sinnone MS; Boschetti E; Nosari AM; Stagni G; Nenci GG; Pauluzzi S
    Ann Intern Med; 1994 Sep; 121(6):423-9. PubMed ID: 8053616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 x 10(9)/L or less. Detailed and updated results from protocol 019 of the AIDS Clinical Trials Group.
    Koch MA; Volberding PA; Lagakos SW; Booth DK; Pettinelli C; Myers MW
    Arch Intern Med; 1992 Nov; 152(11):2286-92. PubMed ID: 1359846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-seropositive thrombocytopenia: the action of zidovudine.
    Boyar A; Beall G
    AIDS; 1991 Nov; 5(11):1351-6. PubMed ID: 1768384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial.
    Lane HC; Falloon J; Walker RE; Deyton L; Kovacs JA; Masur H; Banks S; Kirk LE; Baseler MW; Salzman NP
    Ann Intern Med; 1989 Jul; 111(1):41-50. PubMed ID: 2735626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group.
    Spruance SL; Pavia AT; Mellors JW; Murphy R; Gathe J; Stool E; Jemsek JG; Dellamonica P; Cross A; Dunkle L
    Ann Intern Med; 1997 Mar; 126(5):355-63. PubMed ID: 9054279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
    Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
    Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zidovudine for thrombocytopenic purpura related to human immunodeficiency virus (HIV) infection.
    Oksenhendler E; Bierling P; Ferchal F; Clauvel JP; Seligmann M
    Ann Intern Med; 1989 Mar; 110(5):365-8. PubMed ID: 2916807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
    Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M
    Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of human immunodeficiency virus-related thrombocytopenia with zidovudine.
    Pottage JC; Benson CA; Spear JB; Landay AL; Kessler HA
    JAMA; 1988 Nov; 260(20):3045-8. PubMed ID: 2972851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with zidovudine in patients with human immunodeficiency virus (HIV)-associated thrombocytopenia: modes of response and correlation with markers of HIV replication.
    Cinque P; Landonio G; Lazzarin A; Nosari AM; Ruggieri A; Coen M; Meraviglia P; Gringeri A; Gallo L; Quirino T
    Eur J Haematol; 1993 Jan; 50(1):17-21. PubMed ID: 8094675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful zidovudine therapy for HIV-related severe thrombocytopenia. Report of a sustained remission.
    Peña JM; Arnalich F; Barbado FJ; Dominguez A; Mostaza J; Valencia ME; Vazquez JJ
    Acta Haematol; 1990; 83(2):86-8. PubMed ID: 2106201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
    N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia. NHF-ACTG 036 Study Group.
    Merigan TC; Amato DA; Balsley J; Power M; Price WA; Benoit S; Perez-Michael A; Brownstein A; Kramer AS; Brettler D
    Blood; 1991 Aug; 78(4):900-6. PubMed ID: 1831059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS).
    Kovacs JA; Deyton L; Davey R; Falloon J; Zunich K; Lee D; Metcalf JA; Bigley JW; Sawyer LA; Zoon KC
    Ann Intern Med; 1989 Aug; 111(4):280-7. PubMed ID: 2757312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
    Krown SE; Gold JW; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ
    Ann Intern Med; 1990 Jun; 112(11):812-21. PubMed ID: 1971504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Zidovudine in the treatment of HIV-related thrombocytopenia. A study of 11 cases].
    Steidl L; Gussoni G; Montanari M; Crippa G
    Recenti Prog Med; 1991; 82(7-8):397-8. PubMed ID: 1947405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection.
    Ballem PJ; Belzberg A; Devine DV; Lyster D; Spruston B; Chambers H; Doubroff P; Mikulash K
    N Engl J Med; 1992 Dec; 327(25):1779-84. PubMed ID: 1435932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
    Henry DH; Beall GN; Benson CA; Carey J; Cone LA; Eron LJ; Fiala M; Fischl MA; Gabin SJ; Gottlieb MS
    Ann Intern Med; 1992 Nov; 117(9):739-48. PubMed ID: 1416576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party.
    Bartlett JA; Benoit SL; Johnson VA; Quinn JB; Sepulveda GE; Ehmann WC; Tsoukas C; Fallon MA; Self PL; Rubin M
    Ann Intern Med; 1996 Aug; 125(3):161-72. PubMed ID: 8686973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.